Key result
AF/AFL cases in China are projected to reach ~23 million by 2045.
Why the study?
AF/AFL poses significant risks of heart failure and stroke, and China experienced a major surge in cases from 1990 to 2021, prompting analysis of trends and projected disease burden through 2045.
Observational
The burden of atrial fibrillation and flutter in China is projected to more than double by 2045, reaching 23.04 million prevalent cases, highlighting the urgent need for targeted prevention and healthcare preparedness.
China's rising AF burden may require prevention planning; leaves open drivers and intervention impacts.
Atrial fibrillation/flutter (AF/AFL) poses significant risks of heart failure and stroke. From 1990 to 2021, China's AF/AFL cases surged from 3.20 to 10.78 million. Using Global Burden Disease (GBD) 2021 data and Bayesian age-period-cohort (BAPC) modeling, we analyzed trends and projected disease burden through 2045. Age-standardized incidence and prevalence rose by 5.4% and 14.5%, respectively, while mortality and disability-adjusted life year (DALY) rates declined by 12.2% and 3.8%. By 2045, prevalent cases may reach 23.04 million, with 1.93 million new cases, 220 000 deaths, and 4.21 million DALYs. Key risk factors include hypertension, smoking, high-sodium diet, and obesity. Sex disparities emerged, with females showing better mortality/DALY improvements than males. Population aging and metabolic risks will drive future burden. Targeted interventions (blood pressure control, smoking cessation, sodium reduction) and sex-/age-specific strategies are critical. Innovations in digital health (AI monitoring) and tiered healthcare networks could mitigate risks. Prioritizing China-specific prevention frameworks is essential to address this escalating public health challenge. Geriatr Gerontol Int 2025; 25: 1047-1057.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2025) conducted an observational in Atrial fibrillation/flutter (AF/AFL). Atrial fibrillation and flutter cases in China increased from 3.20 million in 1990 to 10.78 million in 2021, and are projected to reach 23.04 million by 2045.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: